Related Experiment Video
Updated: Jun 17, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
A bibliometric analysis of cardioembolic stroke utilizing HistCite Pro, CiteSpace, and VOSviewer
Dandan Liu1,2, Changyong Fu3, Shiyao Zhang2
1Department of Neurology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Zhenjiang, Jiangsu, China.
Insights
Cardioembolic stroke research is rapidly advancing, with a surge in publications and international collaboration. Key areas include biomarkers, direct oral anticoagulants for embolic stroke of undetermined source (ESUS), and atrial cardiopathy.
Area of Science:
- Neurology
- Bibliometrics
- Public Health
Background:
- Cardioembolic stroke (CES) leads to poorer outcomes compared to other ischemic stroke types.
- A significant increase in research output necessitates a bibliometric analysis to understand trends and contributors.
- This study aims to analyze the developmental trajectory and key research areas in CES.
Purpose of the Study:
- To conduct a comprehensive bibliometric analysis of cardioembolic stroke (CES) research.
- To identify developmental trends, key research hotspots, and major contributors in the CES field.
- To analyze publication characteristics, keyword networks, and collaborative patterns in CES research.
Main Methods:
- Bibliometric analysis of 5498 publications from Web of Science Core Collection (2011-2024).
- Utilized HistCite Pro, CiteSpace, and VOSviewer for data analysis, keyword, and network mapping.
- Examined publication characteristics, institutional contributions, and country/region participation.
Main Results:
- The US and Journal of Stroke & Cerebrovascular Diseases were leading contributors.
- Keyword analysis revealed 6 clusters focusing on biomarkers, CES causes, and direct oral anticoagulant trials for embolic stroke of undetermined source (ESUS).
- Recent research hotspots include direct oral anticoagulants, ESUS, Mendelian randomization, and atrial cardiopathy.
Conclusions:
- CES research shows rapid progress with extensive international collaboration.
- Strengthening global research partnerships can further advance the field.
- Future research should focus on refined etiological phenotyping and personalized secondary prevention for ESUS and related conditions.
Background:
Cardioembolic stroke (CES) often results in poorer outcomes than other ischemic stroke subtypes. Recent years have seen a marked increase in the scientific output of researchers, highlighting the need for a comprehensive bibliometric analysis to clarify the developmental trends, key research hotspots, and primary contributors in this research field.To perform a bibliometric analysis of CES utilizing HistCite Pro, CiteSpace, and VOSviewer.
Methods:
Data were sourced from the Web of Science Core Collection, encompassing publications from January 1, 2011, to January 29, 2024. Publication characteristics were analyzed using HistCite Pro and the Web of Science, whereas VOSviewer and CiteSpace facilitated keyword and collaborative network analyses.
Results:
In total, 5498 publications were identified, originating from 7916 institutions across 112 countries/regions, published in 897 journals, and authored by 29,620 researchers. The annual number of publications surged from 2014 to 2022, with the United States and the Journal of Stroke & Cerebrovascular Diseases leading in contributions. The keyword network revealed 6 key clusters, emphasizing biomarkers, causes of CES, and randomized clinical trials evaluating direct oral anticoagulants for treating embolic stroke of undetermined source (ESUS), CES, and cryptogenic stroke. Recent hotspots included direct oral anticoagulants, ESUS, Mendelian randomization, instruments, and atrial cardiopathy.
Conclusion:
Research on CES has progressed rapidly, and research development and collaboration frequently occur across countries, regions, and institutions. Further strengthening these partnerships may advance the field. The recent focus on ESUS, Mendelian randomization, and atrial cardiopathy highlights the need for refined etiological phenotyping and individualized secondary prevention.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac output averages...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
